Gilead Sciences (GILD) Gross Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-59.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-8.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
188.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-374.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
458.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
234.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-1,705.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-270.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
234.00 |
| Dec 31, 2025 |
40.00 |
| Sep 30, 2025 |
67.00 |
| Jun 30, 2025 |
101.00 |
| Mar 31, 2025 |
11.00 |
| Dec 31, 2024 |
849.00 |
| Sep 30, 2024 |
133.00 |
| Jun 30, 2024 |
-35.00 |
| Mar 31, 2024 |
-116.00 |
| Dec 31, 2023 |
-1,049.00 |
| Sep 30, 2023 |
-239.00 |
| Jun 30, 2023 |
118.00 |
| Mar 31, 2023 |
-45.00 |
| Dec 31, 2022 |
1,737.00 |
| Sep 30, 2022 |
-333.00 |
| Jun 30, 2022 |
-68.00 |
| Mar 31, 2022 |
-42.00 |
| Dec 31, 2021 |
-1,743.00 |
| Sep 30, 2021 |
87.00 |
| Jun 30, 2021 |
-167.00 |
| Mar 31, 2021 |
-372.00 |
| Dec 31, 2020 |
979.00 |
| Sep 30, 2020 |
112.00 |
| Jun 30, 2020 |
-310.00 |
| Mar 31, 2020 |
66.00 |
| Dec 31, 2019 |
-153.00 |
| Sep 30, 2019 |
94.00 |
| Jun 30, 2019 |
359.00 |
| Mar 31, 2019 |
155.00 |
| Dec 31, 2018 |
-598.00 |
| Sep 30, 2018 |
-356.00 |
| Jun 30, 2018 |
-541.00 |
| Mar 31, 2018 |
-496.00 |
| Dec 31, 2017 |
-643.00 |
| Sep 30, 2017 |
-79.00 |
| Jun 30, 2017 |
-466.00 |
| Mar 31, 2017 |
59.00 |
| Dec 31, 2016 |
-220.00 |
| Sep 30, 2016 |
-223.00 |
| Jun 30, 2016 |
99.00 |
| Mar 31, 2016 |
-369.00 |
| Dec 31, 2015 |
205.00 |
| Sep 30, 2015 |
351.00 |
| Jun 30, 2015 |
205.00 |
| Mar 31, 2015 |
465.00 |
| Dec 31, 2014 |
1,297.00 |
| Sep 30, 2014 |
1,080.00 |
| Jun 30, 2014 |
1,455.00 |
| Mar 31, 2014 |
1,426.00 |
| Dec 31, 2013 |
-140.00 |
| Sep 30, 2013 |
30.00 |
| Jun 30, 2013 |
45.00 |
| Mar 31, 2013 |
-183.00 |
| Dec 31, 2012 |
46.00 |
| Sep 30, 2012 |
26.00 |
| Jun 30, 2012 |
39.00 |
| Mar 31, 2012 |
-84.00 |
| Dec 31, 2011 |
-173.00 |
| Sep 30, 2011 |
-306.00 |
| Jun 30, 2011 |
-591.00 |
| Mar 31, 2011 |
-675.00 |
| Dec 31, 2010 |
-154.00 |
| Sep 30, 2010 |
-190.00 |
| Jun 30, 2010 |
-38.00 |
| Mar 31, 2010 |
41.00 |
